|Número de publicación||US6569191 B1|
|Tipo de publicación||Concesión|
|Número de solicitud||US 09/626,638|
|Fecha de publicación||27 May 2003|
|Fecha de presentación||27 Jul 2000|
|Fecha de prioridad||27 Jul 2000|
|También publicado como||EP1361835A1, EP1361835A4, WO2002009617A1|
|Número de publicación||09626638, 626638, US 6569191 B1, US 6569191B1, US-B1-6569191, US6569191 B1, US6569191B1|
|Inventores||James T. Hogan|
|Cesionario original||Bionx Implants, Inc.|
|Exportar cita||BiBTeX, EndNote, RefMan|
|Citas de patentes (17), Citada por (188), Clasificaciones (7), Eventos legales (4)|
|Enlaces externos: USPTO, Cesión de USPTO, Espacenet|
The invention pertains to stents and is particularly adapted to stents made from bioabsorbable materials.
Self-expanding stents, such as braided or woven stents, for surgical implantation in body lumens (tubular vessels) are known for repairing or strengthening the vessels. A stent essentially is a hollow tube that may take the place or at least supplement the body vessel. With respect to the medical condition of stenosis, in which a body lumen tends to collapse or otherwise close, the stent supports the wall of the vessel to prevent it from collapsing or closing. A blood vessel that is narrowed due to the build up of intra-vascular plaque is one example of a stenosis. With respect to the medical condition of aneurism, in which a body lumen is weakened and cannot properly withstand the internal pressure within the vessel and bulges out or ruptures, the stent serves essentially the opposite function in that it substitutes for or supplements a weakened portion of the vessel. Stents are known for insertion in blood vessels, trachea, esophagus, urethra, ureter, nasal passages, ductal systems, etc.
Many different types of stents are commercially available at this time. Most stents need to be radially constricted, i.e., reduced in diameter, in order that they can be more easily inserted into the body lumen. Once they are in situ, the stent can be radially expanded to the desired diameter. Stents are known that are fabricated from rigid, but flexible materials that, when bent by force tend to retain the bent shape. Such stents may be inserted into the body lumen in an unstressed radially minimal shape while mounted over a deflated balloon. When the stent is in situ, the balloon is inflated in order to radially expand the stent, which will then retain the radially expanded shape after the balloon is deflated and removed.
Another type of stent is termed a self-expanding stent. Self-expanding stents may be woven in a variety of single or multiple strand woven designs which can be compressed radially, but will expand to its original shape once the constrictive force is removed. These woven designs are often made of shape memory materials, such as Nitinol, that expands when subjected to body temperature.
Another type of self-expanding stent is disclosed, for instance, in U.S. Pat. No. 1,205,743, issued to Didcott and incorporated herein by reference. Didcott discloses a braided, surgical dilator stent particularly adapted for esophageal dilation, but which can be adapted for use in other body vessels. This patent discloses a stent comprising a hollow tubular member the wall of which is formed of a series of individual flexible thread elements, each of which extends helically around the central longitudinal axis of the stent. A number of the flexible thread elements have the same direction of winding and are displaced relative to each other about the cylindrical surface of the stent. They cross a second plurality of helical thread elements which are also displaced relative to each other about the cylindrical surface of the stent, but having the opposite direction of winding. Accordingly, as shown in FIG. 1, the threads 12 of the first set of threads cross the threads 14 of the second set of threads at crossing points 16. FIG. 1 illustrates an embodiment in which the crossing threads are fully interlaced, however, it should be understood that the crossing threads may be interlaced at other frequencies, e.g., every other crossing point or every third crossing point.
As the stent is axially stretched, i.e., the longitudinal ends 18 and 20 are forced away from each other, the diameter reduces. Likewise, if the wall of the stent is constricted so as to reduce the stent's diameter, the stent elongates. In other words, radial constriction and axial elongation go hand in hand. When the force is released, the stent tends to spring back to its original diameter and length. The force with which the stent returns to its original state depends on many factors including the rigidity of the individual threads, the number of threads, and the original (resting) crossing angle a of the threads. The rigidity of the threads, in turn, depends upon such factors as the material out of which they are fabricated and the thickness of the threads. In general, the greater the rigidity and/or the greater the resting crossing angle of the threads, the greater the radial expansion force.
The desirable radial expansion force for a given stent depends on the application. When used in blood vessels, stents are commonly used to treat stenosis and particularly to hold the vessel open when it has become narrowed by either internal or external forces. Accordingly, such applications require relatively high radial expansion forces. Other applications, such as esophageal applications require much smaller forces.
U.S. Pat. No. 4,655,771 issued to Wallsten discloses a stent of the Didcott design particularly adapted for transluminal implantation in blood vessels for treating stenoses or aneurisms. In some applications, such as the esophageal application particularly discussed in the aforementioned patent to Didcott, the stent is temporary. In other applications, such as the blood vessel application discussed in the aforementioned Wallsten patent, the stent is permanent. In permanent installations, the tissue of the body lumen within which the stent is placed tends to grow around the stent such that the stent essentially becomes incorporated with the tissue of the body vessel and thus becomes permanently affixed. However, in the weeks or months before this occurs, the stent is held in position by friction between the outer surface of the stent body and the inner surface of the vessel created by the radial expansion force of the stent. Thus, the resting diameter of the stent, therefore, is selected to be slightly larger than the inner diameter of the vessel so that there is a constant force between the inner wall of the vessel and the outer wall of the stent.
Bioabsorbable stents are also known in the prior art. Bioabsorbable stents are manufactured from materials which, when exposed to body fluids, dissolve over an extended period of time. Thus, such stents are temporary in the sense that they will eventually dissolve and are eliminated from the body. Such stents are permanent, however, in the sense that there is no separate medical procedure needed to remove the stent from the body, it simply dissolves over time. Various bioabsorbable materials that are suitable for stents are known in the prior art including polymers such as poly-L,D-lactide, poly-L-lactide, poly-D-lactide, bioglass, poly(alpha hydroxy acid), polyglycolic acid, polylactic acid, polycaprolactone, polydioxanone, polyglucanate, polylactic acid-polyelethelene oxide copolymers, tyrosine derived polycarbonate, polyglycolide, modified cellulose, collagen, poly(hydroxybutyrate), polyanhydride, polyphosphoester, poly(amino acids) or combinations thereof. Vainionpää at al., Prog Polym. Sci., vol. 14, pp. 697-716 (1989); U.S. Pat. Nos. 4,700,704, 4,653,497, 4,649,921, 4,599,945, 4,532,928, 4,605,730, 4,441,496, and 4,435,590, all of which are incorporated herein by reference, disclose various compounds from which bioabsorbable stents can be fabricated.
Self-expanding braided stents rely on the spring force of the crossing threads that form the stent body as the radially expanding force. The magnitude of the radially expanding force is, therefore, a function of such factors as the number of threads, the size of the individual threads, the flexibility of the individual threads and the crossing angle of the threads. Self-expanding woven stents rely on a separate set of factors including size and number of threads employed, the flexibility of the individual threads, and the particular weave pattern chosen.
These characteristics of the stent, however, must be chosen based on factors in addition to the desired radial expansion force. For instance, the size of the threads is at least partially limited by the size of the lumen within which it will be employed. Further, characteristics of the material forming the stent body and thus the tensile strength and flexibility of the material is limited to materials which can be safely placed in a human body. Stents made from bioabsorbable materials exhibit different properties than corresponding metallic stent designs. Examples of properties that must be controlled when using bioabsorbable materials include degradation rates, material creep, and material position memory.
Accordingly, it is generally desirable to have various means by which to establish the radial expansion force of the stents. This is particularly true with respect to bioabsorbable stents due to the importance of final position memory associated with bioabsorbable materials.
Therefore, it is an object of the present invention to provide methods and designs to achieve optimum performance when employing bioabsorbable materials in stents.
It is another object of the present invention to provide a self-expanding stent with a supplemental mechanism for increasing the radial expansion force.
The invention applies fully to all stent designs, but is particularly adapted to stents that employ bioabsorbable materials, such as molded, braided and woven self-expanding bioabsorbable stents. The preferred embodiment of the invention comprises a radially self-expanding bioabsorbable stent comprised of a tubular body formed from a first plurality of flexible thread elements each extending in a helical configuration around the longitudinal axis of the stent body in a first direction of winding, a second plurality of flexible thread elements extending in a helical configuration around the longitudinal axis of the stent body having the opposite direction of winding, and a separate force applying mechanism associated with the stent body to axially constrict and/or radially expand the stent body.
In accordance with the helical thread structure of the stent body, the stent has a tendency to take a certain diameter and length. In use, the stent is first radially constricted (and axially elongated) in order to allow it to be more easily maneuvered into position in the body vessel. Once in situ, it is released such that it is allowed to radially expand (and axially constrict) back towards its rest diameter and length. Bioabsorbable polymer stents are subject to material memory effects, such that the amount of constrictive force and the degree of constriction can impart a memory to the stent that will alter the extent to which it will return to its original diameter and length.
Typically, the stent's final rest diameter is chosen to be slightly larger than the inner diameter of the body vessel within which it is placed so that the stent applies a radially outward force against the walls of the vessel tending to hold it in position by friction. The provision of a mechanism for imparting a larger radial diameter memory to the stent, or for supplementing the stent's radial expansion force increases the frictional force of engagement with the walls without the undesirable side effects of prior art means for increasing the radial expansion force, such as increasing the thickness or tensile strength of the threads, increasing the crossing angle of the threads, or increasing the number of threads.
The inventive mechanisms for increasing the radial expansion force include substituting within the stent body one or more particularly rigid threads relative to the other threads. Another mechanism is forming one or more of the helical threads of two side-by-side threads, one of the threads comprised of standard material and the other comprised of a more rigid material. Even further, one or more bands may be longitudinally attached at their ends to the stent body and their ends. The bands may be elastic or inelastic. The bands would tend to counteract any axially elongating force and/or apply an axially constrictive force. The bands may be attached at their ends to the helically wound threads by adhesive or by mechanical means, such as hooks.
In another embodiment, circular or oval bands are woven into the threads forming the wall of the stent. The bands may be elastic or inelastic. The bands are shaped and positioned to resist axially elongation of the stent.
In some embodiments, the longitudinal bands may be fabricated from a material that shrinks in length when exposed to moisture or body temperature. In other embodiments, the supplemental mechanism is fabricated of a bioabsorbable material such that, after an initial period when the extra radial expansion force is most needed, they dissolve and disappear. A primary benefit of increasing the radial expansion force of a bioabsorbable stent and causing an increase in the diameter of the stent in situ is that this larger diameter imparts memory into the stent. The final diameter achieved with self-expanding bioabsorbable stents is directly related, not only to the radial force generated by the stent design, but also the last diameter achieved immediately following stent delivery.
In accordance with another aspect of the present invention, the radial diameter memory of a bioabsorbable self-expanding stent with or without supplemental radial expanding mechanisms is adjusted by inserting the stent into a body vessel in conjunction with an inflatable balloon wherein inflation of the balloon when the stent is in the desired final position will impart a specific radial diameter memory to the stent by producing a temporary radial diameter greater than the stent body alone could create through its own self-expansion force. After some period of time, the balloon is deflated and withdrawn from the vessel.
FIG. 1 is a plan view of a longitudinal portion of a stent in accordance with the prior art.
FIG. 2 is a plan view of a longitudinal portion of a bioabsorbable stent in accordance with a first embodiment of the present invention.
FIG. 3 is a plan view of a longitudinal portion of a bioabsorbable stent in accordance with a second embodiment of the present invention.
FIG. 4 is a plan view of a longitudinal portion of a bioabsorbable stent in accordance with a third embodiment of the present invention.
FIG. 5A is a cross sectional view of an exemplary stent taken along line 5A of FIG. 4 in accordance with one particular embodiment of the present invention.
FIG. 5B is a cross sectional view of an exemplary stent along line 5B of FIG. 4 in accordance with yet another embodiment of the present invention.
FIG. 5C is a cross sectional view of an exemplary stent along line 5C of FIG. 4 in accordance with yet another embodiment of the present invention.
FIG. 6 is a plan view of a longitudinal portion of a stent in accordance with another embodiment of the present invention.
FIG. 7 is a plan view of a stent in accordance with another embodiment of the present invention.
FIG. 8A is a view of the stent prior to delivery into a vessel, with a delivery catheter, an inflation balloon, and a retractable over-sheath that acts to constrain both the dilation balloon and the stent until the time of stent release.
FIG. 8B is a plan view of a portion of the stent and inflatable balloon combination after the initial release of the stent into a body vessel, and prior to expansion of the balloon.
FIG. 8C is a plan view of a portion of the stent and inflatable balloon combination of FIG. 8A in a body vessel after inflation of the balloon.
FIG. 8D is a plan view of a portion of the stent of FIGS. 8A, 8B and 8C embedded in a body vessel after the balloon has been deflated.
FIG. 8E is a plan view of a portion of the stent of FIGS. 8A, 8B, 8C and 8D embedded in a body vessel after the balloon has been withdrawn.
The invention is a stent for implantation in a body vessel such as a blood vessel, trachea, esophagus, urethra, ureter, nasal passage, ductal system, or any tubular passage. Specific design embodiments are disclosed for self-expanding braided or woven stent designs, however all stent designs that incorporate bioabsorbable materials exhibit the “memory” characteristics covered under the invention. FIG. 2 shows a stent 21 in accordance with a first embodiment of the present invention. As is known in the prior art, the stent body is primarily composed of a first set of threads 22 helically wound around the longitudinal axis 24 of the stent 21 and a second plurality of threads 26 helically wound in the opposite direction around the longitudinal axis 24 of the stent. The first and second sets of threads 22 and 26 cross each other at crossing points 28 having crossing angles a. The two sets of threads may or may not be braided with each other. The crossing threads may or may not be joined at the crossing points 18. The threads forming the stent body can be made of any suitable material, including, but not limited to bioabsorbable polymers such as polylactic acid or polyglycolic acid. In this specification, the term bioabsorbable will be used generically to refer to both bioabsorbable materials and bioresorbable materials to the extent that some groups of persons working in the relevant fields may make a distinction between the two terms.
As previously noted, stents of this type are self-expanding in that the diameter of such stents can be reduced and the length commensurately increased by applying either a radially restrictive force or a longitudinally lengthening force. When that force is removed, the stent tends to spring back towards its original diameter and length, but will retain a degree of size memory of the length and diameter to which it was altered. Also as previously noted, the magnitude of the size memory imparted into the stent, as well as the stent's radial expansion force depends on many factors, including the amount of diameter compression or length expansion placed on the stent, the length of time that the size of the stent was altered, the bioabsorbable material used, the rigidity of the threads, the thickness of the threads, the number of threads, and the crossing angle at rest of the threads.
Generally, the greater the crossing angle a at rest, the greater the radial expansion force. The magnitude of the expansion force is important for several reasons. For instance, the expansion force applied against the inner walls of the body vessel within which the stent is installed is the force that holds the stent in place until the tissue of the vessel can grow over and around the stent and thus permanently affix the stent within the vessel. Further, in many applications, the very purpose of the stent is to hold the vessel open and thus the final size memory given to the stent, and the proper magnitude of radial expansion force is critical. In some applications, such as installation in blood vessels, the expansion force needs to be relatively great to hold open the vessel. In others, such as esophageal applications, the force must be considerably less.
In many applications, it may be desirable to supplement the radial expansion force inherently provided by this type of bioabsorbable stent design. For instance, the size of the vessel and/or the route through which the stent must be inserted may dictate that the threads be thin or of a certain number that is insufficient to provide the desired radial expansion force, or the degree to which the stent must be compressed for insertion could impart such reduced radial memory to the stent as to prevent its full expansion.
FIG. 2 discloses a first mechanism for supplementing the radial expansion force of the stent. One or more of the threads 30 may be made of a different material or thickness than the other threads whereby that thread is more rigid than the other threads and thus exerts a greater radial expansion force.
FIG. 3 shows a variation on this mechanism in which one or more of the bioabsorbable threads forming the stent body are replaced with two side-by-side threads 32 and 34. One of the two threads 32 forming each pair or threads is of a standard design, while the other is fabricated of a different material or thickness so that it is more rigid and thus exerts a greater radial expansion force.
It should be understood by those of skill in the art that the greatest need for radial expansion force exists at the moment of insertion and/or for a short period of time thereafter (usually days, weeks or months). Specifically, after a certain period of time, the tissue of the vessel within which the stent is installed grows around the stent, thus more fixedly attaching the stent within the vessel. However, in the first days or weeks, before the tissue has a chance to grow around the stent, the stent relies primarily or exclusively on the friction created by the radial expansion force of the stent against the inner wall of the vessel. Accordingly, the supplemental threads 30 and 34, respectively, in the embodiments of FIGS. 2 and 3 are also made of bioabsorbable material that will dissolve over time. Preferably, the rate at which these threads 30 and 34 dissolve is commensurate with the expected rate of tissue growth over the stent. In embodiments where the threads forming the main stent body are bioabsorbable themselves, the supplemental threads 30 and 34 are preferably bioabsorbed at a faster rate than the main stent body threads.
In alternate embodiments, the supplemental threads do not necessarily need to “replace” normal threads but simply may be woven into the design as extra threads. The supplemental threads may be inside the stent, outside the stent or integrated into the stent braid.
FIG. 4 shows an alternate mechanism for supplementing radial expansion force. In this particular embodiment, the radial expansion force is supplemented by longitudinal strips or bands 40 attached to the helically wound threads that form the wall of the stent and which apply increased longitudinally constricting force, which, of course, increases the radial expansion force. These longitudinal strips or bands 40 are attached at or near their ends 40 a, 40 b to the stent and tend to force the stent body to shorten in length. The ends 40 a, 40 b may be hooked onto the threads or adhered by an adhesive to the stent body. FIG. 5A is a cross sectional view of an exemplary stent taken along line 5A of FIG. 4 in accordance with one particular embodiment of the present invention in which hooks 18 at the ends 40 a and 40 b of the strips hook over the threads 25. FIG. 5B is a cross sectional view of an exemplary stent taken along line 5B of FIG. 4 in accordance with another embodiment of the present invention in which the ends 40 a, 40 b of the strips 40 are adhered by an adhesive 41 to the stent body.
FIG. 5C is a cross sectional view of an exemplary stent taken along line 5C of FIG. 4 in accordance with yet another embodiment of the present invention in which the bands 40 form a continuous band around the stent body such that the bands are essentially trapped within the braiding of the stent itself.
In a preferred embodiment, the strips or bands are elastic. During insertion, the entire stent body, including the bands, are longitudinally stretched. When the stent is released from the insertion apparatus, the stent under its own force as well as the supplemental force applied by the tendency of the strips or bands to constrict back to their rest position provides radial expansion force against the walls of the vessel within which it is inserted. These bands may be positioned on the outside of the stent wall, on the inside of the stent wall or woven among the threads of the stent wall.
In another preferred embodiment of the invention, the supplemental strips or bands 40 are fabricated of a material that shrinks in length when exposed to moisture or body temperature. The shrinkage of the bands 40 will apply a longitudinally constricting and, therefore, radially expansive, force on the stent. Materials that have these properties and that are compatible with insertion into the body are well known and include polylactic and polyglycolic acid, which can be adjusted in their amounts and force of shrinkage through processing, including orientation of their molecular structure.
As discussed above, the threads forming the main stent body as well as the supplemental bands may be fabricated of a bioabsorbable material. In a preferred embodiment, the bands or other supplemental radial expansion mechanism have a higher bioabsorption rate than the main stent body threads.
FIG. 6 shows another embodiment of the invention in which loops 41 are integrated into the stent body 43 by weaving into the threads 27 forming the stent body 43 in a different manner than in the FIG. 4 embodiment. Particularly, each supplemental loop 41 forms a continuous loop which is woven into the body 43 of the stent itself. When the stent is elongated, the loop 41 is elongated and exerts a force tending back towards its original shape thus resisting elongation of the stent body. This longitudinally restricting force, of course, exerts a radially expansive force to the stent. While, for sake of clarity, FIG. 6 shows only one of these loops 41. In a preferred embodiment, two, three or more loops 41 may be incorporated into the stent body arranged radially around the wall. Thus, for instance, four loops may be arranged at 90° intervals around the radial periphery of the stent body as illustrated in FIG. 7 (in which only three of the bands are visible).
In FIGS. 6 and 7, the threads 27 of the stent body as well as the supplemental loops 41 are illustrated as double threads like those discussed above in connection with the embodiment of FIG. 3. However, it should be understood that the supplemental loops 41 and/or the threads 25 forming the stent body 43 can be single strand threads such as threads 28 and 25 illustrated in connection with the embodiments of FIGS. 2 and 4 above.
In accordance with the previously discussed issue of material memory, a self-expanding bioabsorbable stent with or without the supplemental radial expansion force means previously disclosed in this specification may be placed in the body with the assistance of an inflatable balloon to impart final diameter memory to the stent. Systems are available in the prior art for inserting non-self-expanding metallic stents using an insertion apparatus in which the stent is mounted on an inflatable balloon and then inflating the balloon to expand the stent when the desired destination position in the vessel has been reached. It is also known in the prior art to insert radially self-expanding metallic stents with a standard insertion apparatus, to remove the insertion apparatus, and then to insert a balloon into the vessel to a position within the stent and then expand the balloon to radially stretch the stent even further in order to more securely embed it within the vessel, and then remove the balloon.
In accordance with the present invention, the bioabsorbable stent is itself inserted using an insertion apparatus which includes an inflatable balloon positioned adjacent to (including surrounding) the radially constricted/axially elongated stent. When the stent is in the final destination position, the balloon is inflated to expand the stent to a diameter larger than its final resting diameter, thereby imparting a diameter size memory to the stent that will supplement the stent's natural self-expansion force. The balloon is then deflated and the insertion apparatus, including the balloon, is removed from the vessel.
Insertion apparatuses are available in the prior art for inserting non-self-expanding metallic stents in the body and expanding them. However, such delivery devices for non-self-expanding stents would not work in connection with a self-expanding stent because of the tendency of self-expanding stents to radially expand. Particularly, a mechanism must be provided that holds the stent in a radially constricted shape until the stent is delivered to the final release location in the body.
FIGS. 8A, 8B, 8C, 8D and 8E illustrate the progression during insertion of such a stent. FIG. 8A is a view of the delivery system 100 prior to release of the stent into a body lumen 103. The stent 101 and balloon 107 are mounted on a delivery catheter 100 that is inserted into the lumen and guided to the location at which it is to be deployed which, in this example, is a stenosis 105. The delivery catheter 100 preferably comprises a retractable over sheath 102 and an inner shaft 109 through which a gas or liquid can be delivered to the internal space of the balloon 107 in order to inflate it. Preferably, the balloon 107 and the stent 103 are arranged in tandem (one behind the other) in order to minimize the diameter of the catheter delivery system 100. However, in alternate embodiments, the stent 103 can be initially positioned surrounding the balloon 107. The inner shaft 109 includes an annular ring 106 immediately adjacent the distal end of the stent 103 that will prevent the stent from being drawn along with the outer sheath 102 when the outer sheath is retracted. Once the stent 103 has been positioned proximal the stenosis 105, the outer sheath 102 is retracted to release the stent and allow it to radially expand and engage the walls of the lumen (or the stenosis) as shown in FIG. 8B. Once the stent 103 is released, the balloon 107 can be drawn back to a position within the stent and then inflated as shown in FIG. 8C. The stent will not move when the balloon is drawn back because the stent is expanded at this point and is frictionally engaged with the wall of the lumen or stenosis. Also, it is larger than the balloon such that the balloon should not even contact the stent as it is drawn back within the stent.
The inflated balloon further radially expands the stent 101 and imparts a shape memory to the stent of a diameter larger than prior to inflation. In FIG. 8D, the balloon 107 has been deflated and the increased diameter memory has been imparted to the stent. The stent 101 remains at a diameter greater than the diameter that it would have reached had it simply been inserted and released without the additional diameter memory imparted by the balloon 107 during insertion. In FIG. 8E, the insertion apparatus 100 including the balloon 107 has been removed leaving the expanded stent 101 in place in the lumen 103 helping hold the stenosis 105 open.
Having thus described a few particular embodiments of the invention, various alterations, modifications, and improvements will readily occur to those skilled in the art. Such alterations, modifications and improvements as are made obvious by this disclosure are intended to be part of this description though not expressly stated herein, and are intended to be within the spirit and scope of the invention. Accordingly, the foregoing description is by way of example only, and not limiting. The invention is limited only as defined in the following claims and equivalents thereto.
|Patente citada||Fecha de presentación||Fecha de publicación||Solicitante||Título|
|US1205743||25 May 1916||21 Nov 1916||Uriah Hoke||Filter.|
|US4655751||14 Feb 1986||7 Abr 1987||Harbaugh John T||Liquid dispensing and receiving syringe|
|US4954126 *||28 Mar 1989||4 Sep 1990||Shepherd Patents S.A.||Prosthesis comprising an expansible or contractile tubular body|
|US5545208||21 Dic 1993||13 Ago 1996||Medtronic, Inc.||Intralumenal drug eluting prosthesis|
|US5591222||28 Mar 1994||7 Ene 1997||Susawa; Takashi||Method of manufacturing a device to dilate ducts in vivo|
|US5670161 *||28 May 1996||23 Sep 1997||Healy; Kevin E.||Biodegradable stent|
|US5733327 *||17 Oct 1995||31 Mar 1998||Igaki; Keiji||Stent for liberating drug|
|US5766204||12 Sep 1997||16 Jun 1998||Metastent Incorporated||Curable fiber composite stent and delivery system|
|US5997468 *||4 Ago 1997||7 Dic 1999||Medtronic, Inc.||Intraluminal drug eluting prosthesis method|
|US6015432 *||25 Feb 1998||18 Ene 2000||Cordis Corporation||Wire reinforced vascular prosthesis|
|US6161399 *||2 Jul 1998||19 Dic 2000||Iowa-India Investments Company Limited||Process for manufacturing a wire reinforced monolayer fabric stent|
|US6192944 *||24 Abr 2000||27 Feb 2001||Prodesco, Inc.||Method of forming a textile member with undulating wire|
|US6217609 *||30 Jun 1998||17 Abr 2001||Schneider (Usa) Inc||Implantable endoprosthesis with patterned terminated ends and methods for making same|
|US6290731 *||30 Mar 1998||18 Sep 2001||Cordis Corporation||Aortic graft having a precursor gasket for repairing an abdominal aortic aneurysm|
|US6336937 *||9 Dic 1998||8 Ene 2002||Gore Enterprise Holdings, Inc.||Multi-stage expandable stent-graft|
|US6348066 *||14 Ago 1998||19 Feb 2002||Corvita Corporation||Modular endoluminal stent-grafts and methods for their use|
|EP0894505A2||8 Jun 1998||3 Feb 1999||Schneider (Usa) Inc.,||Bioabsorbable self-expanding stent|
|Patente citante||Fecha de presentación||Fecha de publicación||Solicitante||Título|
|US6786919 *||10 Jul 2001||7 Sep 2004||Endovascular Technologies, Inc.||Self-expanding intravascular device with protector members|
|US6805706||15 Ago 2003||19 Oct 2004||Gmp Cardiac Care, Inc.||Stent-graft with rails|
|US7326240 *||30 Nov 1999||5 Feb 2008||Imperial College Of Science, Technology & Medicine||Stents for blood vessels|
|US7326244 *||26 Dic 2001||5 Feb 2008||Drasler William J||Intravascular folded tubular endoprosthesis|
|US7658880||9 Feb 2010||Advanced Cardiovascular Systems, Inc.||Polymeric stent polishing method and apparatus|
|US7662326||16 Feb 2010||Advanced Cardiovascular Systems, Inc.||Compositions containing fast-leaching plasticizers for improved performance of medical devices|
|US7682380||23 Mar 2010||Gore Enterprise Holdings, Inc.||Kink-resistant bifurcated prosthesis|
|US7699890||28 Ene 2004||20 Abr 2010||Advanced Cardiovascular Systems, Inc.||Medicated porous metal prosthesis and a method of making the same|
|US7704275||26 Ene 2007||27 Abr 2010||Reva Medical, Inc.||Circumferentially nested expandable device|
|US7708548||10 Abr 2008||4 May 2010||Advanced Cardiovascular Systems, Inc.||Molds for fabricating stents with profiles for gripping a balloon catheter|
|US7722662||13 Oct 2006||25 May 2010||Reva Medical, Inc.||Expandable stent with sliding and locking radial elements|
|US7731890||15 Jun 2006||8 Jun 2010||Advanced Cardiovascular Systems, Inc.||Methods of fabricating stents with enhanced fracture toughness|
|US7740791||22 Jun 2010||Advanced Cardiovascular Systems, Inc.||Method of fabricating a stent with features by blow molding|
|US7757543||20 Jul 2010||Advanced Cardiovascular Systems, Inc.||Radio frequency identification monitoring of stents|
|US7758881||20 Jul 2010||Advanced Cardiovascular Systems, Inc.||Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device|
|US7761968||27 Jul 2010||Advanced Cardiovascular Systems, Inc.||Method of crimping a polymeric stent|
|US7763065||27 Jul 2010||Reva Medical, Inc.||Balloon expandable crush-recoverable stent device|
|US7794495||14 Sep 2010||Advanced Cardiovascular Systems, Inc.||Controlled degradation of stents|
|US7794776||29 Jun 2006||14 Sep 2010||Abbott Cardiovascular Systems Inc.||Modification of polymer stents with radiation|
|US7823263||9 Jul 2007||2 Nov 2010||Abbott Cardiovascular Systems Inc.||Method of removing stent islands from a stent|
|US7829008||9 Nov 2010||Abbott Cardiovascular Systems Inc.||Fabricating a stent from a blow molded tube|
|US7842737||29 Sep 2006||30 Nov 2010||Abbott Cardiovascular Systems Inc.||Polymer blend-bioceramic composite implantable medical devices|
|US7867547||19 Dic 2005||11 Ene 2011||Advanced Cardiovascular Systems, Inc.||Selectively coating luminal surfaces of stents|
|US7875233||18 Jul 2005||25 Ene 2011||Advanced Cardiovascular Systems, Inc.||Method of fabricating a biaxially oriented implantable medical device|
|US7886419||15 Feb 2011||Advanced Cardiovascular Systems, Inc.||Stent crimping apparatus and method|
|US7892281 *||22 Feb 2011||Medtronic Corevalve Llc||Prosthetic valve for transluminal delivery|
|US7901452||8 Mar 2011||Abbott Cardiovascular Systems Inc.||Method to fabricate a stent having selected morphology to reduce restenosis|
|US7914574||29 Mar 2011||Reva Medical, Inc.||Axially nested slide and lock expandable device|
|US7918854||13 Abr 2007||5 Abr 2011||Howmedica Osteonics Corp.||Non-destructive tissue repair and regeneration|
|US7923022||13 Sep 2006||12 Abr 2011||Advanced Cardiovascular Systems, Inc.||Degradable polymeric implantable medical devices with continuous phase and discrete phase|
|US7947071||24 May 2011||Reva Medical, Inc.||Expandable slide and lock stent|
|US7951185||6 Ene 2006||31 May 2011||Advanced Cardiovascular Systems, Inc.||Delivery of a stent at an elevated temperature|
|US7951194||22 May 2007||31 May 2011||Abbott Cardiovascular Sysetms Inc.||Bioabsorbable stent with radiopaque coating|
|US7955381||29 Jun 2007||7 Jun 2011||Advanced Cardiovascular Systems, Inc.||Polymer-bioceramic composite implantable medical device with different types of bioceramic particles|
|US7959857||14 Jun 2011||Abbott Cardiovascular Systems Inc.||Radiation sterilization of medical devices|
|US7959940||30 May 2006||14 Jun 2011||Advanced Cardiovascular Systems, Inc.||Polymer-bioceramic composite implantable medical devices|
|US7964210||21 Jun 2011||Abbott Cardiovascular Systems Inc.||Degradable polymeric implantable medical devices with a continuous phase and discrete phase|
|US7967998||28 Jun 2011||Advanced Cardiocasvular Systems, Inc.||Method of polishing implantable medical devices to lower thrombogenecity and increase mechanical stability|
|US7971333||30 May 2006||5 Jul 2011||Advanced Cardiovascular Systems, Inc.||Manufacturing process for polymetric stents|
|US7988716 *||25 Abr 2005||2 Ago 2011||Howmedica Osteonics Corp.||Stent for a vascular meniscal repair and regeneration|
|US7988721||4 Dic 2007||2 Ago 2011||Reva Medical, Inc.||Axially-radially nested expandable device|
|US7989018||31 Mar 2006||2 Ago 2011||Advanced Cardiovascular Systems, Inc.||Fluid treatment of a polymeric coating on an implantable medical device|
|US7998404||13 Jul 2006||16 Ago 2011||Advanced Cardiovascular Systems, Inc.||Reduced temperature sterilization of stents|
|US8003156||4 May 2006||23 Ago 2011||Advanced Cardiovascular Systems, Inc.||Rotatable support elements for stents|
|US8007529||30 Ago 2011||Advanced Cardiovascular Systems, Inc.||Medicated porous metal prosthesis|
|US8016879||13 Sep 2011||Abbott Cardiovascular Systems Inc.||Drug delivery after biodegradation of the stent scaffolding|
|US8017237||13 Sep 2011||Abbott Cardiovascular Systems, Inc.||Nanoshells on polymers|
|US8034287||11 Oct 2011||Abbott Cardiovascular Systems Inc.||Radiation sterilization of medical devices|
|US8043553||25 Oct 2011||Advanced Cardiovascular Systems, Inc.||Controlled deformation of a polymer tube with a restraining surface in fabricating a medical article|
|US8048441||1 Nov 2011||Abbott Cardiovascular Systems, Inc.||Nanobead releasing medical devices|
|US8048448||1 Nov 2011||Abbott Cardiovascular Systems Inc.||Nanoshells for drug delivery|
|US8066761||29 Nov 2011||Veryan Medical Limited||Stenting method for blood vessels|
|US8088060||15 Nov 2006||3 Ene 2012||Orbusneich Medical, Inc.||Progenitor endothelial cell capturing with a drug eluting implantable medical device|
|US8099849||13 Dic 2006||24 Ene 2012||Abbott Cardiovascular Systems Inc.||Optimizing fracture toughness of polymeric stent|
|US8128688||19 Jun 2007||6 Mar 2012||Abbott Cardiovascular Systems Inc.||Carbon coating on an implantable device|
|US8137396||19 May 2010||20 Mar 2012||480 Biomedical, Inc||Medical implant|
|US8167787||3 Ene 2008||1 May 2012||Revent Medical, Inc.||Partially erodable systems for treatment of obstructive sleep apnea|
|US8172894||26 Abr 2010||8 May 2012||Reva Medical, Inc.||Circumferentially nested expandable device|
|US8172897||28 Jun 2004||8 May 2012||Advanced Cardiovascular Systems, Inc.||Polymer and metal composite implantable medical devices|
|US8173062||8 May 2012||Advanced Cardiovascular Systems, Inc.||Controlled deformation of a polymer tube in fabricating a medical article|
|US8197879||12 Jun 2012||Advanced Cardiovascular Systems, Inc.||Method for selectively coating surfaces of a stent|
|US8202528||5 Jun 2007||19 Jun 2012||Abbott Cardiovascular Systems Inc.||Implantable medical devices with elastomeric block copolymer coatings|
|US8226704 *||18 Mar 2004||24 Jul 2012||Veryan Medical Limited||Helical stent|
|US8241554||29 Jun 2004||14 Ago 2012||Advanced Cardiovascular Systems, Inc.||Method of forming a stent pattern on a tube|
|US8262723||11 Sep 2012||Abbott Cardiovascular Systems Inc.||Implantable medical devices fabricated from polymer blends with star-block copolymers|
|US8277500||20 Jun 2006||2 Oct 2012||Reva Medical, Inc.||Slide-and-lock stent|
|US8292944||23 Oct 2012||Reva Medical, Inc.||Slide-and-lock stent|
|US8293260||5 Jun 2007||23 Oct 2012||Abbott Cardiovascular Systems Inc.||Elastomeric copolymer coatings containing poly (tetramethyl carbonate) for implantable medical devices|
|US8293367||15 Jul 2011||23 Oct 2012||Advanced Cardiovascular Systems, Inc.||Nanoshells on polymers|
|US8327854||7 Oct 2011||11 Dic 2012||Revent Medical, Inc.||Partially erodable systems for treatment of obstructive sleep apnea|
|US8333000||19 Jun 2006||18 Dic 2012||Advanced Cardiovascular Systems, Inc.||Methods for improving stent retention on a balloon catheter|
|US8343530||22 Dic 2006||1 Ene 2013||Abbott Cardiovascular Systems Inc.||Polymer-and polymer blend-bioceramic composite implantable medical devices|
|US8361103 *||7 Feb 2003||29 Ene 2013||Karla Weaver||Low profile IVC filter|
|US8372133||5 Oct 2009||12 Feb 2013||480 Biomedical, Inc.||Polymeric implant delivery system|
|US8403943||6 Ago 2007||26 Mar 2013||Howmedica Osteonics Corp.||Insertion system for implanting a medical device and surgical methods|
|US8425591||11 Jun 2007||23 Abr 2013||Abbott Cardiovascular Systems Inc.||Methods of forming polymer-bioceramic composite medical devices with bioceramic particles|
|US8435550||7 May 2013||Abbot Cardiovascular Systems Inc.||Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device|
|US8460363||11 Jun 2013||Reva Medical, Inc.||Axially-radially nested expandable device|
|US8460367||15 Nov 2006||11 Jun 2013||Orbusneich Medical, Inc.||Progenitor endothelial cell capturing with a drug eluting implantable medical device|
|US8465789||18 Jul 2011||18 Jun 2013||Advanced Cardiovascular Systems, Inc.||Rotatable support elements for stents|
|US8470014||14 Ago 2007||25 Jun 2013||Advanced Cardiovascular Systems, Inc.||Stent-catheter assembly with a releasable connection for stent retention|
|US8486135||9 Abr 2007||16 Jul 2013||Abbott Cardiovascular Systems Inc.||Implantable medical devices fabricated from branched polymers|
|US8512394||26 Jul 2010||20 Ago 2013||Reva Medical Inc.||Balloon expandable crush-recoverable stent device|
|US8523760||10 Abr 2012||3 Sep 2013||Revent Medical, Inc.||Partially erodable systems for treatment of obstructive sleep apnea|
|US8523936||8 Abr 2011||3 Sep 2013||Reva Medical, Inc.||Expandable slide and lock stent|
|US8535372||18 Jun 2007||17 Sep 2013||Abbott Cardiovascular Systems Inc.||Bioabsorbable stent with prohealing layer|
|US8540762||7 May 2012||24 Sep 2013||Reva Medical, Inc.||Circumferentially nested expandable device|
|US8540765||9 Feb 2012||24 Sep 2013||480 Biomedical, Inc.||Medical implant|
|US8545547||23 May 2011||1 Oct 2013||Reva Medical Inc.||Expandable slide and lock stent|
|US8568469||28 Jun 2004||29 Oct 2013||Advanced Cardiovascular Systems, Inc.||Stent locking element and a method of securing a stent on a delivery system|
|US8592036||20 Sep 2012||26 Nov 2013||Abbott Cardiovascular Systems Inc.||Nanoshells on polymers|
|US8596215||18 Jul 2011||3 Dic 2013||Advanced Cardiovascular Systems, Inc.||Rotatable support elements for stents|
|US8603530||14 Jun 2006||10 Dic 2013||Abbott Cardiovascular Systems Inc.||Nanoshell therapy|
|US8617235||28 Mar 2011||31 Dic 2013||Reva Medical, Inc.||Axially nested slide and lock expandable device|
|US8637110||18 Jul 2011||28 Ene 2014||Advanced Cardiovascular Systems, Inc.||Rotatable support elements for stents|
|US8696735||12 Oct 2011||15 Abr 2014||Veryan Medical Limited||Stents for blood vessels|
|US8696738 *||20 May 2010||15 Abr 2014||Maquet Cardiovascular Llc||Composite prosthesis with external polymeric support structure and methods of manufacturing the same|
|US8707960||11 May 2009||29 Abr 2014||Revent Medical, Inc.||Partially erodable systems for treatment of obstructive sleep apnea|
|US8721708||23 Sep 2011||13 May 2014||Medtronic Corevalve Llc||Prosthetic valve for transluminal delivery|
|US8733363||21 Mar 2011||27 May 2014||Revent Medical, Inc.||Systems and methods for treatment of sleep apnea|
|US8741201 *||9 Sep 2010||3 Jun 2014||Advanced Cardiovascular Systems, Inc.||Fiber reinforced composite stents|
|US8741379||18 Jul 2011||3 Jun 2014||Advanced Cardiovascular Systems, Inc.||Rotatable support elements for stents|
|US8747296||30 Jul 2013||10 Jun 2014||Revent Medical, Inc.||Partially erodable systems for treatment of obstructive sleep apnea|
|US8747878||28 Abr 2006||10 Jun 2014||Advanced Cardiovascular Systems, Inc.||Method of fabricating an implantable medical device by controlling crystalline structure|
|US8747879||31 May 2006||10 Jun 2014||Advanced Cardiovascular Systems, Inc.||Method of fabricating an implantable medical device to reduce chance of late inflammatory response|
|US8752267||9 Ago 2013||17 Jun 2014||Abbott Cardiovascular Systems Inc.||Method of making stents with radiopaque markers|
|US8752268||9 Ago 2013||17 Jun 2014||Abbott Cardiovascular Systems Inc.||Method of making stents with radiopaque markers|
|US8776799||21 Mar 2011||15 Jul 2014||Revent Medical, Inc.||Systems and methods for treatment of sleep apnea|
|US8778256||30 Sep 2004||15 Jul 2014||Advanced Cardiovascular Systems, Inc.||Deformation of a polymer tube in the fabrication of a medical article|
|US8784476||3 Mar 2009||22 Jul 2014||Veryan Medical Limited||Helical stent|
|US8801779||10 May 2011||12 Ago 2014||Medtronic Corevalve, Llc||Prosthetic valve for transluminal delivery|
|US8808342||23 Abr 2013||19 Ago 2014||Abbott Cardiovascular Systems Inc.||Nanoshell therapy|
|US8876896||7 Dic 2011||4 Nov 2014||Medtronic Corevalve Llc||Prosthetic valve for transluminal delivery|
|US8888840 *||16 Abr 2013||18 Nov 2014||Boston Scientific Scimed, Inc.||Drug eluting medical implant|
|US8925177||17 Jul 2012||6 Ene 2015||Abbott Cardiovascular Systems Inc.||Methods for improving stent retention on a balloon catheter|
|US8991398||11 Dic 2012||31 Mar 2015||Revent Medical, Inc.||Partially erodable systems for treatment of obstructive sleep apnea|
|US8992601||13 Feb 2013||31 Mar 2015||480 Biomedical, Inc.||Medical implants|
|US8998986||5 Jul 2013||7 Abr 2015||Zdzislaw B. Malinowski||Nasal stent|
|US9038260||8 May 2014||26 May 2015||Abbott Cardiovascular Systems Inc.||Stent with radiopaque markers|
|US9066799||20 Ene 2011||30 Jun 2015||Medtronic Corevalve Llc||Prosthetic valve for transluminal delivery|
|US9066827||4 Sep 2013||30 Jun 2015||Reva Medical, Inc.||Expandable slide and lock stent|
|US9072820||26 Jun 2006||7 Jul 2015||Advanced Cardiovascular Systems, Inc.||Polymer composite stent with polymer particles|
|US9138335||9 Jul 2012||22 Sep 2015||Syntheon Cardiology, Llc||Surgical implant devices and methods for their manufacture and use|
|US9149378||18 Ago 2008||6 Oct 2015||Reva Medical, Inc.||Axially nested slide and lock expandable device|
|US9155611 *||6 Jul 2006||13 Oct 2015||Cook Medical Technologies Llc||Branch vessel stent graft|
|US9155638 *||10 May 2013||13 Oct 2015||480 Biomedical, Inc.||Drug eluting medical implant|
|US9173733||21 Ago 2006||3 Nov 2015||Abbott Cardiovascular Systems Inc.||Tracheobronchial implantable medical device and methods of use|
|US9173751||13 Sep 2012||3 Nov 2015||Reva Medical, Inc.||Slide-and-lock stent|
|US9198785||4 Dic 2013||1 Dic 2015||Abbott Cardiovascular Systems Inc.||Crush recoverable polymer scaffolds|
|US9248034||23 Ago 2005||2 Feb 2016||Advanced Cardiovascular Systems, Inc.||Controlled disintegrating implantable medical devices|
|US9254213||20 Dic 2004||9 Feb 2016||Rubicon Medical, Inc.||Stent delivery device|
|US9259341||27 Feb 2013||16 Feb 2016||Abbott Cardiovascular Systems Inc.||Methods for improving stent retention on a balloon catheter|
|US9278016||22 Feb 2011||8 Mar 2016||480 Biomedical, Inc.||Medical implant|
|US9283099||25 Ago 2004||15 Mar 2016||Advanced Cardiovascular Systems, Inc.||Stent-catheter assembly with a releasable connection for stent retention|
|US9289201||6 Ago 2007||22 Mar 2016||Howmedica Osteonics Corp.||Medical device for repair of tissue and method for implantation and fixation|
|US9295570||23 Feb 2005||29 Mar 2016||Abbott Laboratories Vascular Enterprises Limited||Cold-molding process for loading a stent onto a stent delivery system|
|US9309347||5 Oct 2011||12 Abr 2016||Biomedical, Inc.||Bioresorbable thermoset polyester/urethane elastomers|
|US9314354||10 May 2013||19 Abr 2016||Reva Medical, Inc.||Axially-radially nested expandable device|
|US9320629||19 Oct 2006||26 Abr 2016||Pfm Medical Ag||Stent for temporary fitting in a body cavity|
|US9358325||22 Abr 2015||7 Jun 2016||Abbott Cardiovascular Systems Inc.||Stents with radiopaque markers|
|US9375326||14 Abr 2014||28 Jun 2016||Maquet Cardiovascular Llc||Composite prosthesis with external polymeric support structure and methods of manufacturing the same|
|US9381109||28 May 2014||5 Jul 2016||Revent Medical, Inc.||Systems and methods for treatment of sleep apnea|
|US9408607||24 Jun 2010||9 Ago 2016||Edwards Lifesciences Cardiaq Llc||Surgical implant devices and methods for their manufacture and use|
|US9408732||11 Mar 2014||9 Ago 2016||Reva Medical, Inc.||Reduced-profile slide and lock stent|
|US9439801||29 Jun 2012||13 Sep 2016||Revent Medical, Inc.||Systems and methods for treatment of sleep apnea|
|US9452068||28 Ago 2013||27 Sep 2016||Reva Medical, Inc.||Expandable slide and lock stent|
|US20020138131 *||20 Mar 2002||26 Sep 2002||Solovay Kenneth S.||Rail stent|
|US20020156523 *||7 Jun 2002||24 Oct 2002||Lilip Lau||Exterior supported self-expanding stent-graft|
|US20020165603 *||1 Jul 2002||7 Nov 2002||Troy Thornton||Kink-resistant bifurcated prosthesis|
|US20030109917 *||18 Jul 2002||12 Jun 2003||Stephen Rudin||Stent vascular intervention device and method|
|US20040158273 *||7 Feb 2003||12 Ago 2004||Scimed Life Systems, Inc.||Low profile IVC filter|
|US20050154443 *||20 Dic 2004||14 Jul 2005||Rubicon Medical, Inc.||Stent delivery device|
|US20050228473 *||5 Abr 2004||13 Oct 2005||David Brown||Device and method for delivering a treatment to an artery|
|US20060020324 *||21 Jul 2004||26 Ene 2006||Schmid Eric V||Balloon expandable crush-recoverable stent device|
|US20060026815 *||3 Oct 2005||9 Feb 2006||Orlando Padilla||Slide and lock stent and method of manufacture from a single piece shape|
|US20060253197 *||8 May 2006||9 Nov 2006||Napier Bradford||Shape-memory port-access tube|
|US20060256161 *||21 Jul 2006||16 Nov 2006||Silverbrook Research Pty Ltd||Ink jet printhead with amorphous ceramic chamber|
|US20060265051 *||18 Mar 2004||23 Nov 2006||Veryan Medical Limited||Helical stent|
|US20070010874 *||6 Jul 2006||11 Ene 2007||Med Institute, Inc.||Branch vessel stent graft|
|US20070067025 *||25 Abr 2005||22 Mar 2007||Bioduct Llc||Stent for a vascular meniscal repair and regeneration|
|US20070179426 *||9 May 2005||2 Ago 2007||Selden Nathan R||Interfacial stent and method of maintaining patency of surgical fenestrations|
|US20070185568 *||13 Abr 2007||9 Ago 2007||Bioduct, Llc||Non-destructive tissue repair and regeneration|
|US20080082154 *||28 Sep 2007||3 Abr 2008||Cook Incorporated||Stent Graft Delivery System for Accurate Deployment|
|US20080082158 *||28 Sep 2007||3 Abr 2008||Cook Incorporated||Method for Deployment of a Stent Graft|
|US20080082159 *||28 Sep 2007||3 Abr 2008||Cook Incorporated||Stent for Endovascular Procedures|
|US20080109067 *||2 Ene 2008||8 May 2008||Imperial College Of Science, Technology & Medicine||Stents for blood vessels|
|US20080183275 *||26 Ene 2007||31 Jul 2008||Eric Schmid||Circumferentially nested expandable device|
|US20090018561 *||12 Sep 2008||15 Ene 2009||Howmedica Osteonics Corp.||Medical device for repair of tissue and method for implantation and fixation|
|US20090177027 *||3 Ene 2008||9 Jul 2009||Gillis Edward M||Partially erodable systems for treatment of obstructive sleep apnea|
|US20100036389 *||6 Ago 2007||11 Feb 2010||Howmedica Osteonics Corp.||Medical device for repair of tissue and method for implantation and fixation|
|US20100042202 *||18 Feb 2010||Kamal Ramzipoor||Composite stent having multi-axial flexibility|
|US20100049220 *||6 Ago 2007||25 Feb 2010||Howmedica Osteonics Corp.||Insertion system for implanting a medical device and surgical methods|
|US20100125326 *||20 Nov 2008||20 May 2010||Medtronic Vascular, Inc.||Braided Stent With a Shortenable Tether|
|US20100249835 *||30 Sep 2010||Howmedica Osteonics Corp.||Medical device for repair of tissue and method for implantation and fixation|
|US20100298952 *||19 May 2010||25 Nov 2010||Arsenal Medical||Medical implant|
|US20110009948 *||13 Ene 2011||Advanced Cardiovascular Systems, Inc.||Fiber Reinforced Composite Stents|
|US20110082464 *||5 Oct 2009||7 Abr 2011||Arsenal Medical, Inc.||Polymeric Implant Delivery System|
|US20110144421 *||11 May 2009||16 Jun 2011||Gillis Edward M||Partially erodable systems for treatment of obstructive sleep apnea|
|US20110153000 *||23 Jun 2011||Howmedica Osteonics Corp.||Non-destructive tissue repair and regeneration|
|US20110226262 *||22 Sep 2011||Gillis Edward M||Systems and methods for treatment of sleep apnea|
|US20110226263 *||22 Sep 2011||Gillis Edward M||Systems and methods for treatment of sleep apnea|
|US20110238162 *||29 Sep 2011||Arsenal Medical||Medical implant|
|US20110288628 *||24 Nov 2011||Maquet Cardiovascular LLC.||Composite prosthesis with external polymeric support structure and methods of manufacturing the same|
|DE102004031014A1 *||26 Jun 2004||12 Ene 2006||Raumedic Ag||Vorrichtung zur gezielten Freistzung von Stoffen in einem Hohlraum|
|WO2006000272A2 *||26 Abr 2005||5 Ene 2006||Raumedic Ag||Device for the targeted release of substances in a cavity|
|WO2006000272A3 *||26 Abr 2005||25 Ene 2007||Raumedic Ag||Device for the targeted release of substances in a cavity|
|WO2010059479A2 *||11 Nov 2009||27 May 2010||Medtronic Vascular Inc.||Braided stent with a shortenable tether|
|WO2010059479A3 *||11 Nov 2009||30 Sep 2010||Medtronic Vascular Inc.||Braided stent with a shortenable tether|
|Clasificación de EE.UU.||623/1.11, 623/1.32, 623/1.2|
|Clasificación internacional||A61F2/90, A61L31/00|
|27 Jul 2000||AS||Assignment|
Owner name: BIONX IMPLANTS, INC., PENNSYLVANIA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:HOGAN, JAMES T.;REEL/FRAME:011006/0941
Effective date: 20000726
|22 Ago 2006||FPAY||Fee payment|
Year of fee payment: 4
|25 Oct 2010||FPAY||Fee payment|
Year of fee payment: 8
|28 Oct 2014||FPAY||Fee payment|
Year of fee payment: 12